Mazdutide and Tirzepatide: How These Dual Pathway Weight Loss Drugs Really Compare Peptides Unleashed Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond ScienceDirect GLP 1s effectiveness at blood pressure control on par with traditional anti hypertensives, tracks well with % weight loss. In someone with hypertension due to their underlying obesity, why not Michael Weintraub, MD Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Cagrilintide More Biotechnology